β-Sheet-Assisted Fabrication of Drug-Loaded Gelatin/Silk Fibroin Nanoparticles for Spinal Cord Injury Treatment
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c01478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Jiangtao Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, State-Key Laboratory of Chemical Engineering, and Shanghai Key Laboratory of Multiphase Materials Chemical Engineerin…. Hauptthemen laut MEDLINE: Gelatin, Fibroins, Spinal Cord Injuries, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Key Research and Development Program of China, State Key Laboratory of Chemical Engineering, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Spinal cord injury (SCI) is a serious neurological disease accompanied by neuroinflammatory responses. Recently, nanosized drug delivery systems have attracted attention for SCI treatment by improving solubility and bioavailability and providing sustained drug release. Protein-based nanoparticles can be biocompatible but often require chemical cross-linkers for structural stability, raising biosafety concerns. Here, we introduce a β-sheet-driven physical cross-linking approach to fabricate nanoparticles without chemical cross-linkers, namely by employing gelatin (Gel) and silk fibroin (SF) as proteins. This coassembly approach ensures structural integrity, enables enzyme-responsive degradation, and allows precise size control with narrow size distributions. Gel/SF particles can load dexamethasone (DEX) with a high drug loading (∼72%), exhibiting long-term stability and enzyme-triggered release. In vitro, these nanoparticles suppress pro-inflammatory cytokines and promote M2 phenotype microglial polarization, suggesting their neuroinflammation-regulating potential. Gel/SF particles may be a biocompatible, cross-linker-free protein-based drug delivery system, offering a promising platform for SCI treatment and broader applications in neuroinflammatory disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering, State-Key Laboratory of Chemical Engineering, and Shanghai Key Laboratory of Multiphase Materials Chemical Engineering, East China University of Science and Technology, Shanghai 200237, C…
- Department of Orthopedic Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, China.
- Physical Chemistry and Soft Matter, Wageningen University and Research, Wageningen 6708 WE, The Netherlands.
- School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Jiangtao Guo, Mingwei Wang, Yuhua Zhang, Junchao Chen, Xuhong Guo
Förderung
- National Key Research and Development Program of China
- State Key Laboratory of Chemical Engineering
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Guo, J., Liu, J., Wang, M., Zhang, Y., Zhang, Z., Cohen Stuart, M., Chen, J., Tang, W., Guo, X., Qi, D., & Liu, T. (2025). β-Sheet-Assisted Fabrication of Drug-Loaded Gelatin/Silk Fibroin Nanoparticles for Spinal Cord Injury Treatment. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c01478
Vancouver
Guo J, Liu J, Wang M, Zhang Y, Zhang Z, Cohen Stuart M, et al. β-Sheet-Assisted Fabrication of Drug-Loaded Gelatin/Silk Fibroin Nanoparticles for Spinal Cord Injury Treatment. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c01478
BibTeX
@article{Guo2025,
author = {Guo, Jiangtao and Liu, Junjie and Wang, Mingwei and Zhang, Yuhua and Zhang, Ziyu and Cohen Stuart, Martien and Chen, Junchao and Tang, Weiping and Guo, Xuhong and Qi, Dahu and Liu, Tao},
title = {β-Sheet-Assisted Fabrication of Drug-Loaded Gelatin/Silk Fibroin Nanoparticles for Spinal Cord Injury Treatment},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c01478}
}
EUVIMED